New eye drops tested for safety in healthy volunteers
NCT ID NCT07370584
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial is testing whether IVMED-85 eye drops are safe for healthy adults aged 18 to 49. About 36 participants will use the eye drops or a placebo twice daily for 6 weeks. The study focuses on vision changes and eye discomfort, not on treating any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY STUDY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Total Eye Care, P.A.
RECRUITINGMemphis, Tennessee, 38119, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.